Clinical and Diagnostic Expertise
NCGS primarily focuses on complex areas of clinical development: oncology-hematology, infectious disease, critical care and CNS in both adult and pediatric populations.
In 30 years of operation, NCGS has worked on the approval or expanded approval of 28 drug, biologic, diagnostic and device products and has had no FDA Warning Letters / 483s. NCGS not only has a unique business model of employing clinical staff with greater than ten years experience , we also possess development expertise in both therapeutic and diagnostic arenas. Therapeutically our range of products encompasses pharmaceuticals, biologics and botanicals.
